Physician profile
Shannon E Mccabe
NPI 1407210362
$4,956.06
in general payments reported to CMS, 2019-2025
6 companies · $3,542 in 2025
The $3,542 reported for 2025 was more than what 90% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2021: $99.31 · 2023: $739 · 2024: $454 · 2025: $3,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,225 · Food and Beverage: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,225.00 |
| Food and Beverage | $1,509.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $3,785.24 | 2023-2025 | Tecnis Iol, Compact Intuitiv, Healon Duet Pro |
| Alcon Vision LLC | $529.81 | 2021-2025 | Clareon |
| Abbvie INC. | $276.93 | 2023-2024 | |
| Sight Sciences, INC. | $209.23 | 2024 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $122.04 | 2019 | |
| Astellas Pharma Global Development | $32.81 | 2025 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.